Effect of Antimicrobial Resistance in the Treatment of Sexually Transmitted Infections


  • Asumah M. Onyeka Department of Pharmaceutical Chemistry, Madonna University, Elele, Rivers State, Nigeria.
  • Chiamaka B. Agbaetuo Department of Clinical Pharmacy, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Kenechukwu E. A. Ujam Servier Pharmaceutical Development ltd, Lagos, Nigeria.
  • Fadilulahi A. Usman Department of Molecular Biology and Biotechnology,
  • Augustine O. Odibo Department of Pharmaceutical Chemistry, University of Benin, Benin City, Nigeria.
  • Chika B. Ojimah Department of Pharmaceutical Microbiology, Delta State University, Abraka, Nigeria.
  • Olabanjo B. Oladoyin Department of Pharmacology and Toxicology, Kaduna State University, Kaduna, Nigeria.
  • Adedoyin E. Daramola  Department of Biology, University of Benin, Benin City, Nigeria




cost of antimicrobials, antimicrobial resistance, Sexually transmitted infections


Background: Sexually transmitted infections (STDs) are hyperendemic in many developing countries where the diagnostic tools and treatment are usually poor. The constant abuse and misuse of antimicrobials have contributed to the emergence and spread of antimicrobial resistance (AMR) in the treatment of STIs. In this review, we looked broadly at the epidemiology of STIs, causative factors,
surveillance reports on AMR, and antimicrobial stewardship, among others.

Methods: Using pertinent keywords like "antimicrobial resistance", "sexually transmitted infections", "treatment effectiveness", and similar terms, the databases of Google Scholar, PubMed, Embase, and the Cochrane Library were searched.

Conclusion: Antimicrobial stewardship implementation is important for the reduction of antimicrobial resistance. In the treatment of sexually transmitted infections, antimicrobial resistance has made it hard with increased morbidity and recurrence. The prevalence of STI's and AMR can be reduced through proper sensitization and health professionals ensuring that antibiotics are used at the
right time, for the right indication, right dose and right dosage form. 


World Health Organization. Antimicrobial resistance. https://www.who.int/newsroom/fact-sheets/detail/antimicrobialresistance. 2021. Accessed August 15, 2023.

Adamu H, Njoku K, Olajide I, Ukponu W, Niyang M (2020) Antimicrobial resistance pattern across two states in Nigeria – A

descriptive/observational study. Int J Infect Dis 2020; 101. https://doi.org/10.1016/j.ijid.2020.09.151

Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect Drug Resist. 2019; 12: 3903 - 3910 https://doi.org/10.2147/IDR.S234610

Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2 0 1 3 ; https://doi.org/10.15585/mmwr.rr7004a1es

Moody J, Cosgrove SE, Olmsted R, Septimus E, Aureden K, Oriola S, Patel GW, Trivedi KK. Antimicrobial stewardship: a collaborative

partnership between infection preventionists and health care epidemiologists. Am J Infect Control. 2012 Mar; 40(2): 94 - 5. doi:


World Health Organisation. Sexually transmitted infections (STIs): key facts. WHO (August 2016).

World Health Organisation. Report on global sexually transmitted infection surveillance, 2018. WHO Library Cataloguing.

World Health Organisation. Global progress report on HIV, viral hepatitis, and sexually transmitted infections. 2021: accountability for

the global health sector strategies 2016–2021: actions for impact. 53:1689–99.

Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N,

Ta y l o r MM. Ch l amy d i a , g o n o rr h o e a , trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-562P. doi: 10.2471/BLT.18.228486.

Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted

Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. PMID: 34292926

Tapera R, Abotseng D, Mhaka-mutepfa M, Baemedi L, Tumoyagae T. Factors contributing to the upsurge of sexually transmitted infections in

Ga b o r o n e , Bo tswa n a . Me d J Zamb i a . 2 0 1 9 ; 4 6 ( 3 ) : 1 9 7 – 2 0 8 . https://doi.org/10.55320/mjz.46.3.558

Ohene S, Akoto I. Factors associated with sexually transmitted infections among young ghana i an women. Ghana Med J. 2008 Sep; 42(3): 96 - 100. doi: 10.4314/gmj.v42i3.43619. https://doi.org/10.4314/gmj.v42i3.43619

Pinto VM, Basso CR, Barros CRDS, Gutierrez EB. Factors associated with sexually transmitted infections: a population based survey in the city of São Paulo, Brazil. Cien Saude Colet. 2018 Jul;23(7):2423-2432. Portuguese, English. doi: 10.1590/1413-81232018237.20602016.

Dagnew GW, Asresie MB, Fekadu GA. Factors associated with sexually transmitted infections among sexually active men in Ethiopia. Further

analysis of 2016 Ethiopian demographic and health survey data. PLoS One. 2020 May 7; 15(5): e0232793. doi:10.1371/journal.pone.0232793.

WHO. World Health Organization. Global health sector strategy on sexually transmitted infections, 2016 - 2021: Toward sending ST Is. WHO/RHR/16.09. Geneva: WHO; 2016; 20(1),58–63.https://www.who.int/publications/i/item/WHO-RHR-16.09 (https://www.who.int/publications/i/item/WHO-RHR-16.09). Accessed August 15, 2023.

Nyblade, L., Stockton, M.A., Giger, K. et al.Stigma in health facilities: why it matters and how we can change it. BMC Med 17, 25 (2019).


Veldhuijzen NJ, van Steijn M, Nyinawabega J, Kestelyn E, Uwineza M, Vyankandondera J, van de Wijgert JH. Prevalence of sexually transmitted

infections, genital symptoms and health-care seeking behaviour among HIV-negative female sex workers in Kigali, Rwanda. Int J STD AIDS.

Feb; 24(2): 139 - 43. doi:10.1177/0956462412472293.

World Health Organization. Global health sector strategy on sexually transmitted infections 2016-2021: toward ending STIs 2016:

National Population Commission (NPC). Nigeria Demographic Health Survey 2018. The DHS Program ICF Rockville, Maryland, USA, 748.

https://dhsprogram.com/publications/publication-fr359-dhs-final-reports. c fm(https://dhsprogram.com/publications/publi

cation-fr359-dhs-final-reports.cfm). Accessed August 15, 2023.

Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli

M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2 0 1 3 Dec;13(12):1057-98. doi: 10.1016/S1473-099(13)70318-9. Epub 2013 Nov 17. Erratum in: Lancet Infect Dis. 2014 Jan;14(1):11. Erratum in: Lancet Infect Dis. 2014 Mar;14(3):182. https://doi.org/10.1016/S1473 -3099(13)70318-9

Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies.

Antimicrob Resist Infect Control. 2017 May 15;6:47. doi: 10.1186/s13756-017-0208-x. https://doi.org/10.1186/s13756-017-0208-x

Saleh N, Awada S, Awwad R, Jibai S, Arfoul C, Zaiter L, Dib W, Salameh P. Evaluation of antibiotic prescription in the Lebanese

community: a pilot study. Infect Ecol Epidemiol. 2015 Jun 24;5:27094. doi: 10.3402/iee.v5.27094. https://doi.org/10.3402/iee.v5.27094

Cosgrove E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care

costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9. 1

Dyar OJ, Huttner B, Schouten J, Pulcini C; ESGAP (ESCMID Study Group for Antimicrobial stewardshiP). What is

antimicrobial stewardship? Clin Microbiol Infect. 2017 Nov; 23(11): 793 - 798. doi : 10.1016/j.cmi.2017.08.026.

Centers for Disease Control and Prevention [CDC], National Action Plan for Combating Antibiotic-Resistant Bacteria (National Action

Plan). US Department of Health & Human Services; 2015 . https://www.cdc.gov/drugresistance/usactivities/national-action-plan.html

(https://www.cdc.gov/drugresistance/usactivities/national-action-plan.html) Accessed August 15, 2023

Dinh A, Duran C, Davido B, Bouchand F, Deconinck L, Matt M, Sénard O, Guyot C, Levasseur AS, Attal J, Razazi D, Tritz T, Beauchet

A, Salomon J, Beaune S, Grenet J. Impact of an antimicrobial stewardship programme to optimize antimicrobial use for outpatients at an

emergency department. J Hosp Infect. 2017 Nov; 97(3): 288 - 293. doi:10.1016/j.jhin.2017.07.005.

Madanchi H, Shoushtari M, Kashani HH, Sardari S. Antimicrobial peptides of the vaginal innate immunity and their role in the fight against

sexually transmitted diseases. New Microbes New Infect. 2019 Dec 10;34:100627. doi: 10.1016/j. nmni. 2019. 100627. https://doi.org/10.1016/j.nmni.2019.100627.

Culver KD, Hicks LM. In silico prediction and mass spectrometric characterization of botanical antimicrobial peptides. Methods Enzymol.

;663: 157 - 175. doi: 10.1016/bs.mie.2021.11.002. Epub 2021 Dec 21.

Castro-Sánchez E, Drumright LN, Gharbi M, Farrell S, Holmes AH. Mapping Antimicrobial Stewardship in Undergraduate Medical, Dental,

Pharmacy, Nursing and Veterinary Education in the United Kingdom. PLoS One. 2016 Feb 29; 11(2): e0150056. doi: 10. 1371/journal. pone. 015005 6. https://doi.org/10.1371/journal.pone.0150056

Brinkman DJ, Tichelaar J, Graaf S, Otten RHJ, Richir MC, van Agtmael MA. Do final-year medical students have sufficient prescribing

competencies? Asystematic literature review. Br J Clin Pharmacol. 2018 Apr;84(4):615-635. doi: 10.1111/bcp.13491. Epub 2018 Jan 25


Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, Ndowa F, Martin I, Dillon JR, Galas M, Ramon-Pardo P, Weinstock H, Wi T.

WHO globa l antimi c robi a l r e sist anc e surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet

Microbe. 2021 Nov;2(11):e627-e636. doi: 10.1016/S2666-5247(21)00171-3. Epub 2021 Sep 2. https://doi.org/10.1016/S2666-5247(21)00171-3

World Health Organisation [WHO]. Report on globa l s exua lly tr ansmitt ed inf e c tion surveillance, 2018. WHO Library Cataloguing.

Weston EJ, Wi T, Papp J. Strengthening Global Surveillance for Antimicrobial Drug-Resistant Neisseria gonorrhoeae through the Enhanced

Gonococcal Antimicrobial Surveillance Program. Emerg Infect Dis. 2017 Oct;23(13):S47–52. doi: 10. 3201/eid2313. 170443.


Tien V, Punjabi C, Holubar MK. Antimicrobial resistance in sexually transmitted infections. J Travel Med. 2020 Feb 3;27(1):taz101. doi:

1093/jtm/taz101. https://doi.org/10.1093/jtm/taz101

World Health Organisation. Global progress report on HIV, viral hepatitis, and sexually transmitted infections. 2021: Accountability for

the global health sector strategies 2016–2021: Actions for impact. Volume 53:1689–99.

St Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K, Torrone E, Weinstock H, Kersh EN, Thorpe P. Update to CDC's

Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep. 2020 Dec 18; 69 (50): 1911 - 1916. doi:

15585/mmwr. m m 6 9 5 0 a 6 . https://doi.org/10.15585/mmwr.mm6950a6

Tapera R, Abotseng, D, et al. Factors contributing to the upsurge of sexually transmitted infections in Gaborone, Botswana. Med J Zambia. 2019. 46(3):197–208.

Kakooza F, Kiggundu R, Mboowa G, Kateete PD, Nsangi OT, Kabahita JM, Ssentalo Bagaya B, Golparian D, Unemo M. Antimicrobial

susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review. Front

Microbiol. 2023 Apr6 ; 14: 1148817. https://doi.org/10.3389/fmicb.2023.1148817

Riou J, Althaus CL, Allen H, Cole MJ, Grad YH, Heijne JCM, Unemo M, Low N. Projecting the development of antimicrobial resistance in

Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study. BMC Infect Dis. 2023 Apr 20;23(1):252.

doi: 10.1186/s12879-023-08200-4.

Maurakis SA, Cornelissen CN. Recent Progress Towards a Gonococcal Vaccine. Front Cell Infect Microbiol. 2022 Apr 11;12:881392. doi:

3389/fcimb.2022.881392. https://doi.org/10.3389/fcimb.2022.881392

O'Neal P. Antimicrobial resistance: Tackling a crisis for the wealth and health of nations. Review on Antimicrobial Resistance, 2014;1: 1–16.

Jadimurthy R, Mayegowda SB, Nayak SC, Mohan CD, Rangappa KS. Escaping mechanisms of ESKAPE pathogens from antibiotics and their

targeting by natural compounds. Biotechnol Rep(Amst) . 2022Apr 4; 34: e00728. https://doi.org/10.1016/j.btre.2022.e00728

Ghareeb MA, Habib MR, Mossalem HS et al. Phytochemical analysis of Eucalyptus camaldulensis leaves extracts and testing its

antimicrobial and schistosomicidal activities. Bulletin of the National Research Centre2 0 1 8 : 4 2 ( 1 ) , p . 1 6 . https://doi.org/10.1186/s42269-018-0017-2

van de Wijgert J, Verwijs MC. Lactobacillicontaining vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic

review and recommendations for future trial designs. BJOG. 2020 Jan;127(2):287-299. doi: 10.1111/1471-0528.15870..

Madanchi H, Shoushtari M, Kashani HH, Sardari S. Antimicrobial peptides of the vaginal innate immunity and their role in the fight against

sexually transmitted diseases. New Microbes New Infect. 2019 Dec 10;34:100627. doi: 10.1016/j.nmni.2019.100627.,

Tanphaichitr N, Srakaew N, Alonzi R, Kiattiburut W, Kongmanas K, Zhi R, Li W, Baker M, Wang G, Hickling D. Potential Use of Antimicrobial

Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel). 2016 Mar 11;9(1):13. doi: 10.3390/ph9010013. https://doi.org/10.3390/ph9010013




How to Cite

Onyeka, A. M., Agbaetuo, C. B., Ujam, K. E. A., Usman, F. A., Odibo, A. O., Ojimah, C. B., … Daramola , A. E. (2024). Effect of Antimicrobial Resistance in the Treatment of Sexually Transmitted Infections. The Nigerian Journal of Pharmacy, 58(1), 33–41. https://doi.org/10.51412/psnnjp.2024.04